← Open Payments lookup

JOEL LURIE: Open Payments

NPI 1497273841 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$691 in 17 payments from 13 companies in 2025. Trend: 2023 $706 · 2024 $630 · 2025 $691

Food & beverage: $691
CompanyPaymentsAmount
ARGENX US, INC.2$145
GlaxoSmithKline, LLC.1$122
ABBVIE INC.1$120
Janssen Biotech, Inc.1$45
Lilly USA, LLC2$43
TerSera Therapeutics LLC2$40
AstraZeneca Pharmaceuticals LP1$33
Amgen Inc.2$29
Daiichi Sankyo Inc.1$27
Lundbeck LLC1$26

Products named: VYVGART, NUCALA, SKYRIZI, TREMFYA, KISUNLA, Quzyttir, SAPHNELO, INJECTAFER.

Industry payments across TX — which companies pay providers there.